These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 12566373

  • 1. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
    Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, Quintana M, Alvarez-Sabín J.
    Circulation; 2003 Feb 04; 107(4):598-603. PubMed ID: 12566373
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
    Montaner J, Alvarez-Sabín J, Molina CA, Anglés A, Abilleira S, Arenillas J, Monasterio J.
    Stroke; 2001 Dec 01; 32(12):2762-7. PubMed ID: 11739970
    [Abstract] [Full Text] [Related]

  • 3. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J, Fernández-Cadenas I, Molina CA, Monasterio J, Arenillas JF, Ribó M, Quintana M, Chacón P, Andreu AL, Alvarez-Sabín J.
    Stroke; 2003 Dec 01; 34(12):2851-5. PubMed ID: 14605329
    [Abstract] [Full Text] [Related]

  • 4. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A.
    Stroke; 2004 Jul 01; 35(7):1671-6. PubMed ID: 15166391
    [Abstract] [Full Text] [Related]

  • 5. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M, Fernández-Cadenas I, Alvarez-Sabín J, Rosell A, Quiroga D, Cuadrado E, Delgado P, Rubiera M, Ribó M, Molina C, Montaner J.
    Cerebrovasc Dis; 2009 Jul 01; 28(2):143-50. PubMed ID: 19546541
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
    Montaner J, Alvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, González MA, Monasterio J.
    Stroke; 2001 Aug 01; 32(8):1759-66. PubMed ID: 11486102
    [Abstract] [Full Text] [Related]

  • 7. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.
    Chen H, Guan B, Chen X, Chen X, Li C, Qiu J, Yang D, Liu KJ, Qi S, Shen J.
    Transl Stroke Res; 2018 Oct 01; 9(5):515-529. PubMed ID: 29275501
    [Abstract] [Full Text] [Related]

  • 8. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.
    Exp Neurol; 2015 Apr 01; 266():120-6. PubMed ID: 25708985
    [Abstract] [Full Text] [Related]

  • 9. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
    García-Yébenes I, García-Culebras A, Peña-Martínez C, Fernández-López D, Díaz-Guzmán J, Negredo P, Avendaño C, Castellanos M, Gasull T, Dávalos A, Moro MA, Lizasoain I.
    Stroke; 2018 Sep 01; 49(9):2163-2172. PubMed ID: 30018160
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
    Ohtani R, Nakamura M, Nirengi S, Kawakami O, Togawa J, Doi K, Sainouchi M, Kuwata Y, Takata M, Masuda Y, Matsunari R, Takeda K, Tsukahara T, Sakane N.
    J Stroke Cerebrovasc Dis; 2019 Jul 01; 28(7):1979-1986. PubMed ID: 30982718
    [Abstract] [Full Text] [Related]

  • 11. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N, Tasneem N, Shaban A, Dandapat S, Ahmed U, Policeni B, Olalde H, Shim H, Samaniego EA, Pieper C, Ortega-Gutierrez S, Leira EC, Adams HP.
    J Stroke Cerebrovasc Dis; 2018 May 01; 27(5):1403-1411. PubMed ID: 29398533
    [Abstract] [Full Text] [Related]

  • 12. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
    Castellanos M, Sobrino T, Millán M, García M, Arenillas J, Nombela F, Brea D, Perez de la Ossa N, Serena J, Vivancos J, Castillo J, Dávalos A.
    Stroke; 2007 Jun 01; 38(6):1855-9. PubMed ID: 17478737
    [Abstract] [Full Text] [Related]

  • 13. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion.
    Molina CA, Alvarez-Sabín J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, Romero F, Codina A.
    Stroke; 2002 Jun 01; 33(6):1551-6. PubMed ID: 12052990
    [Abstract] [Full Text] [Related]

  • 14. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.
    Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD, CASES Investigators.
    Stroke; 2007 Jan 01; 38(1):75-9. PubMed ID: 17122437
    [Abstract] [Full Text] [Related]

  • 15. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Jan 01; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 16. Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains.
    Chen HS, Chen XM, Feng JH, Liu KJ, Qi SH, Shen JG.
    CNS Neurosci Ther; 2015 Jul 01; 21(7):585-90. PubMed ID: 25996167
    [Abstract] [Full Text] [Related]

  • 17. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
    Muhammad S, Planz O, Schwaninger M.
    Cerebrovasc Dis Extra; 2016 Jul 01; 6(2):50-9. PubMed ID: 27560521
    [Abstract] [Full Text] [Related]

  • 18. Sonographic evaluation of hemorrhagic transformation and arterial recanalization in acute hemispheric ischemic stroke.
    Seidel G, Cangür H, Albers T, Burgemeister A, Meyer-Wiethe K.
    Stroke; 2009 Jan 01; 40(1):119-23. PubMed ID: 18988915
    [Abstract] [Full Text] [Related]

  • 19. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L, Millán M, de la Ossa NP, Guerrero C, Gomis M, López-Cancio E, Ricciardi AC, Dávalos A.
    Eur J Neurol; 2010 Feb 01; 17(2):301-6. PubMed ID: 19912320
    [Abstract] [Full Text] [Related]

  • 20. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD, Bennink E, van Seeters T, Kappelle LJ, van der Graaf Y, Mali WPTM, de Jong HWAM, Velthuis BK, Dankbaar JW, DUST Investigators.
    Cerebrovasc Dis; 2018 Feb 01; 45(1-2):26-32. PubMed ID: 29402765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.